Dr. Maurie Markman comments on a study published in the Journal of Clinical Oncology demonstrating the benefit of anti-EGFR therapy in this difficult-to-treat population. Medscape Genomic Medicine
In this expert column, Dr. Vincent Miller and Dr. Trever Bivona discuss the importance of biomarkers in selecting NSCLC patients for treatment with targeted therapies. Medscape Hematology-Oncology
High plasma levels of pentraxin 3 (PTX3), a marker of vascular inflammation, predict adverse clinical outcomes in patients with heart failure, Japanese clinicians report. Reuters Health Information
High FGF-23 independently predicts the risk for end-stage renal disease in patients with relatively mild chronic kidney disease and risk for death regardless of CKD severity. br / iMedscape Medical News/i
Interferon gamma assays can replace tuberculin skin tests for diagnosing latent tuberculosis in children, and particularly in those in whom skin tests results are confounded by previous vaccinations or infections, according to a study from Cambodia. Reuters Health Information
